# BioMap

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biomap

- Industry: Biotechnology
- Headquarters: Beijing, China
- Website: www.biomap.com
- Total disclosed funding: $100M
- Latest round: Series A (Jul 30, 2021)
- Investors on record: 5

## About

Founded in 2020 and based in Beijing, China, BioMap operates as a biotechnology company that focuses on the operation and management of life science platforms. The company was co-founded by the former BV Baidu Ventures bio-intelligence team and its 50 global portfolio companies. It was recognized as the National High-tech Enterprise. Wei Liu, the CEO of the company, graduated from Cambridge University and used to serve as Vice President of Baidu, CEO of Baidu Ventures, and Chairman of Comet Labs, etc. BioMap has branch offices in Beijing, HongKong, and the Silicon Valley. The company closed its series A funding in 2021. In 2023, the company cooperated with Sanofi. In June 2024, BioMap closed a strategic investment from new investor Hong Kong Investment Corporation.

BioMap mainly engages in the operation and management of life science platforms. Its biocomputing platform utilizes algorithms, smart sensors, smart chips, micro-nano robots, and other AI technologies to solve life science problems. The platform provides services such as data collection, multidimensional data mining and analysis, computational drug design, and high-throughput automated experimental validation. The company also engages in the development of AI drugs, such as single-cell precision medicine diagnostic and therapeutic products.

The company generates revenue by operating life science platforms.

The company plans to set up a biocomputing innovation center, InnoHub, in Hong Kong. The company will continue to increase its investment in Hong Kong over the next 3 years.

## Funding rounds

- Series A, Jul 30, 2021, $100M — BlueRun Ventures, Legend Capital, Baidu, Xiang He Capital, Jiyuan Capital

## Investors

- BlueRun Ventures (https://capitalatlas.ai/funds/bluerun-ventures) — Series A
- Legend Capital — Series A
- Baidu — Series A
- Xiang He Capital (https://capitalatlas.ai/funds/xiang-he-capital) — Series A
- Jiyuan Capital (https://capitalatlas.ai/funds/jiyuan-capital) — Series A